{"id":"https://openalex.org/W2079387346","doi":"https://doi.org/10.1016/s0021-5198(19)31388-5","title":"GTS-21, a Nicotinic Agonist, Protects against Neocortical Neuronal Cell Loss Induced by the Nucleus Basalis Magnocellularis Lesion in Rats","display_name":"GTS-21, a Nicotinic Agonist, Protects against Neocortical Neuronal Cell Loss Induced by the Nucleus Basalis Magnocellularis Lesion in Rats","alternate_titles":[],"publication_year":1997,"publication_date":"1997-07-01","ids":{"openalex":"https://openalex.org/W2079387346","doi":"https://doi.org/10.1016/s0021-5198(19)31388-5","mag":"2079387346","pmid":"https://pubmed.ncbi.nlm.nih.gov/9268090"},"language":"en","primary_location":{"id":"doi:10.1016/s0021-5198(19)31388-5","doi":"https://doi.org/10.1016/s0021-5198(19)31388-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0021-5198(19)31388-5","pdf_url":null,"source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2079387346"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1016/s0021-5198(19)31388-5","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068685904","display_name":"Masato Nanri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Masato Nanri","raw_affiliation_strings":["Department of Pharmacology, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090993084","display_name":"Nobuo Kasahara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nobuo Kasahara","raw_affiliation_strings":["Department of Pharmacology, Taiho Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Taiho Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005710979","display_name":"Jyunji Yamamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jyunji Yamamoto","raw_affiliation_strings":["Department of Pharmacology, Taiho Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Taiho Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111699026","display_name":"Hidekazu Miyake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hidekazu Miyake","raw_affiliation_strings":["Department of Pharmacology, Taiho Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Taiho Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071346122","display_name":"Hiroshi Watanabe","orcid":"https://orcid.org/0000-0001-9268-4144","observed_orcids":["https://orcid.org/0000-0001-9268-4144"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroshi Watanabe","raw_affiliation_strings":["Department of Pharmacology, Research Institute for Wakan-Yaku (Oriental Medicines), Toyama Medical and Pharmaceutical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Institute for Wakan-Yaku (Oriental Medicines), Toyama Medical and Pharmaceutical University","institution_ids":["https://openalex.org/I42766147"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5068685904"],"corresponding_institution_ids":["https://openalex.org/I4210120269"],"apc_list":null,"apc_paid":null,"fwci":1.0984,"has_fulltext":false,"cited_by_count":31,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.74518549,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"74","issue":"3","first_page":"285","last_page":"289"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.015699999406933784,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gts-21","display_name":"GTS-21","score":1.0},{"id":"https://openalex.org/keywords/nicotinic-agonists","display_name":"nicotinic agonists","score":0.8970000147819519},{"id":"https://openalex.org/keywords/excitotoxic-lesions","display_name":"excitotoxic lesions","score":0.777999997138977},{"id":"https://openalex.org/keywords/neuronal-loss","display_name":"neuronal loss","score":0.8960000276565552},{"id":"https://openalex.org/keywords/parietal-cortex","display_name":"parietal cortex","score":0.8429999947547913},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.8410000205039978},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8759999871253967},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C2778205193","wikidata":"https://www.wikidata.org/wiki/Q1813830","display_name":"Nucleus basalis","level":4,"score":0.8292513489723206},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.6892931461334229},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5817486643791199},{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.5512807369232178},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4718955457210541},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4058918356895447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4022533893585205},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33015137910842896},{"id":"https://openalex.org/C22885893","wikidata":"https://www.wikidata.org/wiki/Q4862743","display_name":"Cholinergic","level":2,"score":0.31227701902389526},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27924442291259766},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2390522062778473},{"id":"https://openalex.org/C104966671","wikidata":"https://www.wikidata.org/wiki/Q12167532","display_name":"Cholinergic neuron","level":3,"score":0.23872193694114685},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1417258083820343},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13680174946784973}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001597","descriptor_name":"Benzylidene Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009538","descriptor_name":"Nicotine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013377","descriptor_name":"Substantia Innominata","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0021-5198(19)31388-5","doi":"https://doi.org/10.1016/s0021-5198(19)31388-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0021-5198(19)31388-5","pdf_url":null,"source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},{"id":"doi:10.1254/jjp.74.285","doi":"https://doi.org/10.1254/jjp.74.285","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.74.285","pdf_url":null,"source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Japanese Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:9268090","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9268090","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese journal of pharmacology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1016/s0021-5198(19)31388-5","doi":"https://doi.org/10.1016/s0021-5198(19)31388-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0021-5198(19)31388-5","pdf_url":null,"source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1964196236","https://openalex.org/W1982064952","https://openalex.org/W1988360408","https://openalex.org/W2001656611","https://openalex.org/W2010806189","https://openalex.org/W2015272601","https://openalex.org/W2021114817","https://openalex.org/W2037877036","https://openalex.org/W2039101445","https://openalex.org/W2041699031","https://openalex.org/W2069317157","https://openalex.org/W2081133904","https://openalex.org/W2092541011","https://openalex.org/W2163815564","https://openalex.org/W2338521704"],"related_works":["https://openalex.org/W2079117719","https://openalex.org/W1977330670","https://openalex.org/W2147134466","https://openalex.org/W2039101445","https://openalex.org/W2067676128","https://openalex.org/W2091472815","https://openalex.org/W2010220594","https://openalex.org/W2072740341","https://openalex.org/W2042639976","https://openalex.org/W2016333981"],"abstract_inverted_index":{"Effect":[0],"of":[1,29,51],"subchronically":[2],"administered":[3,37],"GTS-21":[4,34,60,73],"[3-(2,4-dimethoxybenzylidene)-anabaseine":[5],"dihydrochloride],":[6],"a":[7,75,90],"selective":[8],"nicotinic":[9],"agonist,":[10],"on":[11,93],"neuronal":[12,80],"cell":[13,44,81],"loss":[14,45,65],"caused":[15],"by":[16],"nucleus":[17],"basalis":[18],"magnocellularis":[19],"(nBM)":[20],"lesion":[21],"was":[22,35,46],"studied":[23],"in":[24,48,55,66,83],"rats.":[25,59],"After":[26],"2":[27],"weeks":[28],"bilateral":[30],"nBM":[31],"excitotoxic":[32],"lesion,":[33],"orally":[36],"once":[38],"daily":[39],"for":[40],"20":[41],"weeks.":[42],"Neuronal":[43],"observed":[47],"layers":[49],"II-III":[50],"the":[52,56,63,79,84],"parietal":[53,85],"cortex":[54,86],"lesioned":[57],"control":[58],"significantly":[61],"attenuated":[62],"neuron":[64],"these":[67],"layers.":[68],"These":[69],"results":[70],"suggest":[71],"that":[72],"exhibits":[74],"protective":[76],"action":[77],"against":[78],"death":[82],"and":[87],"may":[88],"have":[89],"beneficial":[91],"effect":[92],"neurodegenerative":[94],"disorders":[95],"such":[96],"as":[97],"an":[98],"Alzheimer-type":[99],"disease.":[100]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2079387346","counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
